Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Siemens AG    SIE   DE0007236101

News SummaryMost relevantAll newsSector news 

Siemens AG : WSJ BLOG/Health : Siemens Sees Resurgence in Diagnostics as a Cost Cutter

share with twitter share with LinkedIn share with facebook
share via e-mail
04/13/2012 | 07:02pm CET

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Shirley S. Wang

The Health Blog caught up at TEDMED with Gregory Sorensen, chief executive of Siemens Healthcare in North America, to talk about the changing health-care field and what it means for diagnostics, an area in which Siemens is a player.

"We're beginning to see resurgence in diagnostics as a way to save costs, " Sorensen, formerly a radiology professor at Harvard Medical School, told the Health Blog.

A missed diagnosis is a big cost driver in health care because it wastes time and money on ineffective therapy, he said, pointing to an example of studies in Alzheimer's showing that upon autopsy, some 15%-20% of patients examined had a different ailment than believed and would have been treated differently when they were alive.

Of course, there's been an outcry about the unnecessary use of medical tests and Sorensen acknowledges there has been overuse in the past. Reductions in Medicare reimbursement rates have curbed overuse, he says, though not everyone agrees on that, as the Health Blog reported last week. The important thing now, Sorensen says, is to make sure people are getting the right diagnostic tests, rather than reduce the absolute number of them.

He recalled being a doctor in training in the late 1980s, when his professors taught him that, because of the risks associated with appendicitis, doctors should be conservative whenever a patient reported pain in the lower right quadrant of the abdomen. A good surgeon, therefore, would do exploratory surgery on five patients for every one that actually had appendicitis. Sorensen himself had his appendix -- which turned out to be healthy -- removed during this era.

Now patients get scanned if they report such pain, resulting in many fewer unnecessary surgeries, said Sorensen.

Siemens recognizes how important it is to demonstrate effectiveness in today's health-care business, and that payers want to see results, says Sorensen. As for the shift to reimbursement for value, "that train has left the station."

 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SIEMENS AG
12/07 SIEMENS : Electric motor from Siemens sets new world climb record
12/06 SIEMENS : to host Germany-wide young researchers competition
11/30 Siemens hires Cisco manager to add high-tech acumen to board
11/30 SIEMENS : accelerates implementation of Vision 2020 and expands Managing Board
11/26 OSRAM LICHT : Siemens is well placed to adapt business in U.S. - CEO
11/24DJSIEMENS : U.S. Executive Leads Siemens Through Tough Times
11/17 E ON : says CFO Michael Sen to move back to Siemens
11/15DJSiemens Deepens Push to Digitize -- WSJ
11/14DJSiemens to Buy Mentor Graphics Amid Push to Digitize Factories
11/14 Siemens boosts software business with $4.5 billion deal
More news
Sector news : Industrial Conglomerates
12/09DJGENERAL ELECTRIC : GE Boosts Dividend 4.3%
12/09DJGEMALTO : to Buy 3M's Identity-Management Business
12/09 GEMALTO : 3M to sell identity management business to Gemalto
12/09DJGEMALTO : to Buy 3M's Identity-Management Business for $850 Million
12/08 DuPont CEO Breen says Trump win unlikely to impact Dow deal
More sector news : Industrial Conglomerates
News from SeekingAlpha
12/07 Siemens targets double-digit annual digital business growth through 2020
11/28 Smartphone Prices Will Collapse Soon
11/28 5 Dividends That Make The Difference
11/25 ITALIAN REFERENDUM : What To Expect And What To Do
11/22 Mentor Graphics posts solid Q3 ahead of planned Siemens merger
Financials (€)
Sales 2017 83 448 M
EBIT 2017 8 415 M
Net income 2017 5 828 M
Debt 2017 16 687 M
Yield 2017 3,30%
P/E ratio 2017 15,72
P/E ratio 2018 14,51
EV / Sales 2017 1,37x
EV / Sales 2018 1,29x
Capitalization 97 495 M
More Financials
Duration : Period :
Siemens AG Technical Analysis Chart | SIE | DE0007236101 | 4-Traders
Full-screen chart
Technical analysis trends SIEMENS AG
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 115 €
Spread / Average Target 0,46%
Consensus details
EPS Revisions
More Estimates Revisions
Josef Kaeser President & Chief Executive Officer
Gerhard Cromme Chairman-Supervisory Board
Ralf Peter Thomas Chief Financial Officer
Siegfried Russwurm Chief Technology Officer
Helmuth Ludwig Chief Information Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SIEMENS AG27.61%102 933
3M CO18.49%107 356
E I DU PONT DE NEMOURS..12.39%65 070
More Results